November 4-5, 2013. For at least three years in a row, LABVANTAGE has attended the Leaders in Biobanking Congress event. “Today, biospecimen collections are used by multiple research groups for varying research aims, from basic research through clinical trials. A well-managed biobank is a critical prerequisite for high-quality biological research. Cambridge Healthtech Institute’s Fifth Annual Leaders in Biobanking: Maximizing Your Investment in Biospecimens addresses both the business and science of biobanking, bringing together biomedical and biopharmaceutical researchers, regulators, biorespository managers and practitioners to investigate the best strategies for effective use of biospecimens within today’s cutting-edge research.” We welcome you to stop by and see us at this event. LABVANTAGE will be at booth seven.